Personal information

No personal information available

Activities

Collapse all

Works (24)

Azacitidine in combination with shortened venetoclax treatment cycles in patients with acute myeloid leukemia

Annals of Hematology
2024-10-25 | Journal article
DOI: 10.1007/s00277-024-06048-5
Part of ISSN: 0939-5555
Part of ISSN: 1432-0584
Contributors: Maximilian Fleischmann; Madlen Jentzsch; Annamaria Brioli; Florian Eisele; Jochen J. Frietsch; Farina Eigendorff; Romy Tober; Karin G. Schrenk; Jakob Friedrich Hammersen; Olaposi Yomade et al.
Source: Self-asserted source
Jochen J Frietsch

Outcomes after allogeneic haematopoietic stem cell transplantation in young adults in Germany

British Journal of Haematology
2023-04 | Journal article
DOI: 10.1111/bjh.18610
Contributors: Jochen J. Frietsch; Sarah Flossdorf; James F. Beck; Nicolaus Kröger; Katharina Fleischhauer; Peter Dreger; Johannes Schetelig; Martin Bornhäuser; Andreas Hochhaus; Inken Hilgendorf
Source: check_circle
Crossref

Sex-Disaggregated Analysis of Biology, Treatment Tolerability, and Outcome of Multiple Myeloma in a German Cohort

Oncology Research and Treatment
2022 | Journal article
DOI: 10.1159/000525493
Contributors: Annamaria Brioli; Theresa Maria Nägler; Olaposi Yomade; Maria Madeleine Rüthrich; Sebastian Scholl; Jochen J. Frietsch; Inken Hilgendorf; Thomas Ernst; Herbert Gottfried Sayer; Andreas Hochhaus et al.
Source: check_circle
Crossref

Psychosocial distress in young adults surviving hematological malignancies: a pilot study

Journal of Cancer Research and Clinical Oncology
2022-12-17 | Journal article
DOI: 10.1007/s00432-022-04527-8
Part of ISSN: 0171-5216
Part of ISSN: 1432-1335
Contributors: Andreas Wittwer; Kristin Sponholz; Jochen J Frietsch; Paul Linke; Peter Kropp; Andreas Hochhaus; Inken Hilgendorf
Source: Self-asserted source
Jochen J Frietsch

Combination of treosulfan, fludarabine and cytarabine as conditioning in patients with acute myeloid leukemia, myelodysplastic syndrome and myeloproliferative neoplasms

Journal of Cancer Research and Clinical Oncology
2022-10 | Journal article
DOI: 10.1007/s00432-021-03836-8
Contributors: Samantha O‘Hagan Henderson; Jochen J. Frietsch; Inken Hilgendorf; Andreas Hochhaus; Claus-Henning Köhne; Jochen Casper
Source: check_circle
Crossref

Treosulfan plus fludarabine versus TEAM as conditioning treatment before autologous stem cell transplantation for B-cell Non-Hodgkin lymphoma

Bone Marrow Transplantation
2022-05-10 | Journal article
DOI: 10.1038/s41409-022-01701-x
Part of ISSN: 0268-3369
Part of ISSN: 1476-5365
Source: Self-asserted source
Jochen J Frietsch
grade
Preferred source (of 2)‎

Clinical experience with venetoclax in patients with newly diagnosed, relapsed, or refractory acute myeloid leukemia

Journal of Cancer Research and Clinical Oncology
2022-01-31 | Journal article
DOI: 10.1007/s00432-022-03930-5
Part of ISSN: 0171-5216
Part of ISSN: 1432-1335
Source: Self-asserted source
Jochen J Frietsch

Publisher Correction: SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders

Leukemia
2021-12 | Journal article
DOI: 10.1038/s41375-021-01365-4
Contributors: Alexander Kaiser; Martin Schmidt; Otmar Huber; Jochen J. Frietsch; Sebastian Scholl; Florian H. Heidel; Andreas Hochhaus; Jörg P. Müller; Thomas Ernst
Source: check_circle
Crossref

Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy

Journal of Cancer Research and Clinical Oncology
2021-10-05 | Journal article
DOI: 10.1007/s00432-021-03821-1
Part of ISSN: 0171-5216
Part of ISSN: 1432-1335
Source: Self-asserted source
Jochen J Frietsch

The incidental discovery of a constitutional trisomy 21 mosaicism in an adult female with myelodysplastic/myeloproliferative neoplasm

Annals of Hematology
2021-09-01 | Journal article
DOI: 10.1007/s00277-021-04655-0
Part of ISSN: 0939-5555
Part of ISSN: 1432-0584
Source: Self-asserted source
Jochen J Frietsch

Combination of Treosulfan, Fludarabine and Cytarabine as Conditioning in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome and Myeloproliferative Neoplasms

2021-07-26 | Other
DOI: 10.21203/rs.3.rs-731909/v1
Contributors: Samantha O'Hagan Henderson; Jochen J Frietsch; Inken Hilgendorf; Andreas Hochhaus; Claus-Henning Köhne; Jochen Casper
Source: check_circle
Crossref

Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia

Journal of Cancer Research and Clinical Oncology
2021-07-23 | Journal article
DOI: 10.1007/s00432-021-03733-0
Part of ISSN: 0171-5216
Part of ISSN: 1432-1335
Source: Self-asserted source
Jochen J Frietsch

Improved gene delivery to K-562 leukemia cells by lipoic acid modified block copolymer micelles

Journal of Nanobiotechnology
2021-03-06 | Journal article
DOI: 10.1186/s12951-021-00801-y
Contributors: Friederike Richter; Prosper Mapfumo; Liam Martin; Jana I. Solomun; Franziska Hausig; Jochen J. Frietsch; Thomas Ernst; Stephanie Hoeppener; Johannes C. Brendel; Anja Traeger
Source: check_circle
Crossref

Extra-medullary recurrence of myeloid leukemia as myeloid sarcoma after allogeneic stem cell transplantation: impact of conditioning intensity

Bone Marrow Transplantation
2021-01-30 | Journal article
DOI: 10.1038/s41409-020-0984-4
Contributors: Jochen J. Frietsch; Friederike Hunstig; Christoph Wittke; Christian Junghanss; Tobias Franiel; Sebastian Scholl; Andreas Hochhaus; Inken Hilgendorf
Source: check_circle
Crossref

SIRT7: an influence factor in healthy aging and the development of age-dependent myeloid stem-cell disorders

Leukemia
2020-08-01 | Journal article
DOI: 10.1038/s41375-020-0803-3
Contributors: Alexander Kaiser; Martin Schmidt; Otmar Huber; Jochen J. Frietsch; Sebastian Scholl; Florian H. Heidel; Andreas Hochhaus; Jörg P. Müller; Thomas Ernst
Source: check_circle
Crossref

Knockout of LASP1 in CXCR4 expressing CML cells promotes cell persistence, proliferation and TKI resistance

Journal of Cellular and Molecular Medicine
2020-03 | Journal article
DOI: 10.1111/jcmm.14910
Contributors: Andreas B. Herrmann; Martha‐Lena Müller; Martin F. Orth; Jörg P. Müller; Alma Zernecke; Andreas Hochhaus; Thomas Ernst; Elke Butt; Jochen J. Frietsch
Source: check_circle
Crossref

A 19-year-old patient with atypical chronic myeloid leukemia

Annals of Hematology
2020-03-19 | Journal article
Part of DOI: 10.1007/s00277-020-03992-w
Part of ISSN: 0939-5555
Part of ISSN: 1432-0584
Source: Self-asserted source
Jochen J Frietsch

Phosphorylation-Dependent Differences in CXCR4-LASP1-AKT1 Interaction between Breast Cancer and Chronic Myeloid Leukemia

Cells
2020-02 | Journal article | Author
DOI: 10.3390/cells9020444
Contributors: Elke Butt; Katrin Stempfle; Lorenz Lister; Felix Wolf; Marcella Kraft; Andreas B Herrmann; Cristina Perpina Viciano; Christian Weber; Andreas Hochhaus; Thomas Ernst et al.
Source: check_circle
Multidisciplinary Digital Publishing Institute

A Mosquito Bite with Devastating Complications in an Immunocompromised Patient

Case Reports in Oncology
2019-01-04 | Journal article
DOI: 10.1159/000495878
Contributors: Jochen J. Frietsch; Nils Winkelmann; Friederike Hunstig; Ulf Schnetzke; Friedrich J. Hammersen; Torsten Dönicke; Mark Lenz; Florian Gras; Sebastian Scholl; Andreas Hochhaus et al.
Source: check_circle
Crossref

In Vivo Emergence of UL56 C325Y Cytomegalovirus Resistance to Letermovir in a Patient with Acute Myeloid Leukemia after Hematopoietic Cell Transplantation

Mediterranean Journal of Hematology and Infectious Diseases
2019-01-01 | Journal article
DOI: 10.4084/mjhid.2019.001
Contributors: Jochen J Frietsch; Detlef Michel; Thomas Stamminger; Friederike Hunstig; Sebastian Birndt; Ulf Schnetzke; Sebastian Scholl; Andreas Hochhaus; Inken Hilgendorf
Source: check_circle
Crossref

LASP1 is a novel BCR-ABL substrate and a phosphorylation-dependent binding partner of CRKL in chronic myeloid leukemia

Oncotarget
2014 | Journal article
DOI: 10.18632/oncotarget.2072
Source: Self-asserted source
Jochen J Frietsch

Paradoxical MAPK-activation in response to treatment with tyrosine kinase inhibitors in CML: flow cytometry loses track

Cytometry. Part B, Clinical cytometry
2014 | Journal article
DOI: 10.1002/cyto.b.21091
Source: Self-asserted source
Jochen J Frietsch

Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review

European journal of haematology
2014 | Journal article
DOI: 10.1111/ejh.12311
Source: Self-asserted source
Jochen J Frietsch

Nuclear localisation of LASP-1 correlates with poor long-term survival in female breast cancer

British journal of cancer
2010 | Journal article
DOI: 10.1038/sj.bjc.6605685
Source: Self-asserted source
Jochen J Frietsch
How many people are using ORCID?